Cargando…

Mechanisms of resistance to mitochondria-targeted therapy in pancreatic cancer

Detalles Bibliográficos
Autores principales:	Boukalova, Stepana, Ezrova, Zuzana, Neuzil, Jiri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351600/ https://www.ncbi.nlm.nih.gov/pubmed/34381567 http://dx.doi.org/10.18632/oncotarget.27976

Ejemplares similares

A simple indirect colorimetric assay for measuring mitochondrial energy metabolism based on uncoupling sensitivity
por: Herst, Patries M., et al.
Publicado: (2020)

Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors
por: Hubackova, Sona, et al.
Publicado: (2020)

Mitochondrial DNA Affects the Expression of Nuclear Genes Involved in Immune and Stress Responses in a Breast Cancer Model
por: Grasso, Carole, et al.
Publicado: (2020)

Mitochondria break through cellular boundaries
por: Neuzil, Jiri, et al.
Publicado: (2019)

Targeting mitochondria as an anticancer strategy
por: Dong, Lanfeng, et al.
Publicado: (2019)

Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells
por: Vanova, K., et al.
Publicado: (2016)

A mitochondria-targeted nano-platform for pancreatic cancer therapy
por: Tan, Xiaoke, et al.
Publicado: (2022)

Mitochondria on the move: Horizontal mitochondrial transfer in disease and health
por: Dong, Lan-Feng, et al.
Publicado: (2023)

Simultaneous targeting of mitochondrial metabolism and immune checkpoints as a new strategy for renal cancer therapy
por: Stemberkova‐Hubackova, Sona, et al.
Publicado: (2022)

Targeting mitochondria to stimulate hematopoiesis
por: Girotra, Mukul, et al.
Publicado: (2020)

Mitochondria-Targeted Drug Delivery
por: Kopecka, Joanna
Publicado: (2022)

Mitochondria and Cancer
por: Parr, Ryan, et al.
Publicado: (2013)

Mitochondria and cancer
por: Chandel, Navdeep S
Publicado: (2014)

Mitochondria and Cancer
por: Bazhin, Alexandr V.
Publicado: (2020)

MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126
por: Neuzil, Jiri, et al.
Publicado: (2023)

Mitochondria-adaptor TRAK1 promotes kinesin-1 driven transport in crowded environments
por: Henrichs, Verena, et al.
Publicado: (2020)

Advances in Mitochondria-Targeted Drug Delivery
por: Bottani, Emanuela, et al.
Publicado: (2023)

Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy
por: Dong, Lanfeng, et al.
Publicado: (2020)

New Insights into Metabolic Alterations and Mitochondria Re-Arrangements in Pancreatic Adenocarcinoma
por: Dando, Ilaria, et al.
Publicado: (2023)

Pros and Cons of Use of Mitochondria-Targeted Antioxidants
por: Plotnikov, Egor Y., et al.
Publicado: (2019)

Targeting mitochondria to extend physically active lifespan
por: Ahn, Bumsoo
Publicado: (2023)

Novel Germline SUCLG2 Mutations in Patients With Pheochromocytoma and Paraganglioma
por: Vanova, Katerina Hadrava, et al.
Publicado: (2021)

Emerging concepts in cancer therapy: Mechanisms of resistance
por: Gupta, Seema, et al.
Publicado: (2022)

Special Issue: Resistance to Targeted Therapies in Human Cancer
por: Lee, Tae-Won, et al.
Publicado: (2023)

Cancer stemness and progression: mitochondria on the stage
por: Chiarugi, Paola, et al.
Publicado: (2015)

Remodeling of Mitochondria in Cancer and Other Diseases
por: Teng, Yong
Publicado: (2023)

Mitochondria Targeting as an Effective Strategy for Cancer Therapy
por: Ghosh, Poorva, et al.
Publicado: (2020)

Miro proteins and their role in mitochondrial transfer in cancer and beyond
por: Nahacka, Zuzana, et al.
Publicado: (2022)

Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells
por: Kazi, Julhash U.
Publicado: (2020)

Mitochondria and Aging
por: Leeuwenburgh, Christiaan, et al.
Publicado: (2011)

Mitochondria and Cytoprotection
por: Brenner, Catherine, et al.
Publicado: (2012)

Mitochondria and diabetes
por: Siasos, Gerasimos, et al.
Publicado: (2020)

Neoadjuvant therapy for resectable pancreatic cancers
por: Inoue, Yosuke, et al.
Publicado: (2022)

Pulling the plug – halting cancer's theft of mitochondria
por: Marlein, Christopher R., et al.
Publicado: (2017)

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
por: Tamburrino, Anna, et al.
Publicado: (2013)

Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics
por: Cintas, Célia, et al.
Publicado: (2018)

Targeting IL-17 for pancreatic cancer prevention
por: McAllister, Florencia, et al.
Publicado: (2014)

Smart Design of Mitochondria-Targeted and ROS-Responsive CPI-613 Delivery Nanoplatform for Bioenergetic Pancreatic Cancer Therapy
por: Zhang, Yi-Mei, et al.
Publicado: (2021)

Transient targeting of the pancreatic cancer stroma as a ‘fine-tuned’ anti-tumor and anti-metastatic therapy
por: Vennin, Claire, et al.
Publicado: (2017)

Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines
por: Masuo, Hitoshi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gpnitu16j3kfarmm0d7eerrf3t